These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 28657186)
1. Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases. Bersani G; Prevete E Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657186 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness. Gray R; Bressington D; Hughes E; Ivanecka A J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639 [TBL] [Abstract][Full Text] [Related]
3. [Acting out and psychoactive substances: alcohol, drugs, illicit substances]. Gillet C; Polard E; Mauduit N; Allain H Encephale; 2001; 27(4):351-9. PubMed ID: 11686057 [TBL] [Abstract][Full Text] [Related]
4. Novel psychoactive substance use among treatment-seeking opiate users: The role of life events and psychiatric symptoms. Kapitány-Fövény M; Farkas J; Pataki PA; Kiss A; Horváth J; Urbán R; Demetrovics Z Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28618002 [TBL] [Abstract][Full Text] [Related]
5. Novel psychoactive substances in young adults with and without psychiatric comorbidities. Martinotti G; Lupi M; Acciavatti T; Cinosi E; Santacroce R; Signorelli MS; Bandini L; Lisi G; Quattrone D; Ciambrone P; Aguglia A; Pinna F; Calò S; Janiri L; di Giannantonio M Biomed Res Int; 2014; 2014():815424. PubMed ID: 25133182 [TBL] [Abstract][Full Text] [Related]
6. Pathways through care of severely mentally ill individuals experiencing multiple public crisis events: a qualitative description. Hensen MJ; de Mooij LD; Theunissen J; Dekker J; Willemsen M; Zoeteman J; Peen J; de Wit MA BMC Psychiatry; 2016 Apr; 16():84. PubMed ID: 27036706 [TBL] [Abstract][Full Text] [Related]
7. Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study. Acciavatti T; Lupi M; Santacroce R; Aguglia A; Attademo L; Bandini L; Ciambrone P; Lisi G; Migliarese G; Pinna F; Quattrone D; Ribolsi M; Signorelli MS; Calò S; Schifano F; di Giannantonio M; Martinotti G Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28517032 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions. Bennett KH; Hare HM; Waller RM; Alderson HL; Lawrie S BMJ Open; 2017 Dec; 7(12):e015716. PubMed ID: 29203502 [TBL] [Abstract][Full Text] [Related]
9. Consideration of the influence of place on access to employment for persons with serious mental illness in northeastern Ontario. Rebeiro Gruhl KL; Kauppi C; Montgomery P; James S Rural Remote Health; 2012; 12():2034. PubMed ID: 22839731 [TBL] [Abstract][Full Text] [Related]
10. New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects. Taflaj B; La Maida N; Tittarelli R; Di Trana A; D'Acquarica I Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273431 [TBL] [Abstract][Full Text] [Related]
11. Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014. Matsumoto T; Tachimori H; Takano A; Tanibuchi Y; Funada D; Wada K Psychiatry Clin Neurosci; 2016 Dec; 70(12):560-566. PubMed ID: 27527499 [TBL] [Abstract][Full Text] [Related]
12. Use of psychotropic medication groups in people with severe mental illness and stressful childhood experiences. Schneeberger AR; Muenzenmaier K; Castille D; Battaglia J; Link B J Trauma Dissociation; 2014; 15(4):494-511. PubMed ID: 24678974 [TBL] [Abstract][Full Text] [Related]
13. [Psychiatric pharmacotherapy of older individuals with severe mental illness]. Lange-Asschenfeldt C Z Gerontol Geriatr; 2018 Nov; 51(7):770-778. PubMed ID: 30302537 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and service use of incarcerated males with severe mental disorders: a comparative case-control study with patients found not criminally responsible. Dumais A; Côté G; Larue C; Goulet MH; Pelletier JF Issues Ment Health Nurs; 2014 Aug; 35(8):597-603. PubMed ID: 25072212 [TBL] [Abstract][Full Text] [Related]
15. The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents. Paruk S; Jhazbhay K; Singh K; Sartorius B; Burns JK J Child Adolesc Ment Health; 2017 Nov; 29(3):219-229. PubMed ID: 29092669 [TBL] [Abstract][Full Text] [Related]
16. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol. Khaled SM; Hughes E; Bressington D; Zolezzi M; Radwan A; Badnapurkar A; Gray R Syst Rev; 2016 Nov; 5(1):195. PubMed ID: 27871332 [TBL] [Abstract][Full Text] [Related]
18. Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS. Lee S; Rothbard AB; Noll E; Blank MB Adm Policy Ment Health; 2011 Sep; 38(5):335-44. PubMed ID: 20976619 [TBL] [Abstract][Full Text] [Related]
19. The phenomenon of social isolation in the severely mentally ill. Linz SJ; Sturm BA Perspect Psychiatr Care; 2013 Oct; 49(4):243-54. PubMed ID: 25187445 [TBL] [Abstract][Full Text] [Related]